Journal of Natural Products
Article
Retention times of AA Marfey’s derivatives: D-di-Cl-Hpla 3.29 min (L-
di-Cl-Hpla 2.99, D-di-Cl-Hpla 3.29 min), D-leucine 46.89 min (L-Leu
43.8, D-Leu 46.9 min), L-Choi-6α-OH 36.3 min (L-Choi-6α-OH 36.3,
L-Choi-6β-OH 35.0 min).
(1H, dd, J = 14.0, 4.0 Hz, H-3′), 7.18 (2H, s, H-5, H-9), 9.70 (1H, s, 7-
OH); 13C NMR (DMSO-d6, 125 MHz) δ175.3 (C, C-1), 71.1 (CH,
C-2), 38.9 (CH2, C-3), 132.0 (C, C-4), 129.8 (CH × 2, C-5,5′), 122.1
(C × 2, C-6,6′), 147.7 (C, C-7); HRESIMS m/z 248.9725, [M − H]−
(calcd for C9H735Cl2O4, 248.9721).
Preparation of m-Bromo-m′-chloro-D,L-p-hydroxyphenyllac-
tic Acid (9) (ref 13). To a stirring solution of hydroxyphenyllactic
acid (10 mg) in 2 mL of CH3CN was added 0.1 equiv of TsOH in
CH3CN (2 mL). After 5 min of stirring 1.1 equiv (8.1 mg) of N-
chlorosuccinimide in CH3CN (2 mL) was added in one portion. The
reaction was left to stir at room temperature for 6 h. Then 1.1 equiv
(10.8 mg) of N-bromosuccinimide in CH3CN (2 mL) was added in
one portion. The reaction was left to stir at room temperature for 18 h.
For the workup, the CH3CN solution was diluted with EtOAc (20
mL) and washed three times with a 5% aqueous solution of Na2S2O3
(25 mL), followed by three washes with water (25 mL) and then with
brine (25 mL). After evaporation of the solvents under vacuum, the
solid was subjected to a preparative reversed-phase HPLC column
(YMC-pack ODS-A, 5 μm, 250 × 20 mm, DAD at 238 nm, flow rate
5.0 mL/min) eluted with 1:1 0.1% aqueous TFA/MeOH to afford m-
bromo-m′-chloro-D,L-p-Hpla (9, 7.2 mg, 44% yield, retention time 21.7
min) and m,m-dichloro-D,L-p-Hpla (11, 2.9 mg, 21% yield, retention
time 23.5 min).
Determination of the Absolute Configuration of the Amino
Acids. Compounds 1−5 (0.3 mg each) were hydrolyzed in 6 N HCl
(1 mL). The reaction mixture was maintained in a sealed glass bomb at
110 °C for 16 h. The acid was removed in vacuo, and the residue was
resuspended in 250 μL of H2O. FDAA solution [(1-fluoro-2,4-
dinitrophenyl)-5-L-alanine amide] in acetone (115 μL, 0.03 M) and
NaHCO3 (120 μL, 1M) were added to each reaction vessel. The
reaction mixture was stirred at 40 °C for 2 h. Then HCl (2 M, 60 μL)
was added to each reaction vessel, and the solution was evaporated in
vacuo. The FDAA-amino acid derivatives from the hydrolysate were
dissolved in 1 mL of CH3CN and compared with standard FDAA-
amino acids by HPLC analysis: LiChrospher 60, RP-select B (5 μm),
flow rate 1 mL/min, UV detection at 340 nm, linear gradient elution
from 9:1 0.1% aqueous TFA buffer, pH 3: CH3CN to CH3CN, within
60 min. The absolute configuration of each amino acid was determined
by spiking the derivatized hydrolysates with a D,L-mixture of the
standard derivatized amino acids.
Determination of the Absolute Configuration of Hydroxy
Phenyl Lactic Acid Derivatives. Extraction of the acid hydrolysates
of compounds 1−5 with ethyl ether separated the Hpla derivatives
from the amino acid salts. The ether was removed in vacuo, and the
residue was dissolved in MeOH (1 mL). The MeOH solution was
analyzed on an Astec, Chirobiotic, LC stationary phase, 250 × 4.6 mm,
flow rate 1 mL/min, UV detection at 277 nm, linear elution with 1:19
1% aqueous triethylamnium acetate buffer, pH 4: MeOH. The Hpla
derivative from the aeruginosins was compared with corresponding
synthetic standard D,L-Hpla derivatives.
m-Bromo-m′-chloro-D,L-p-hydroxyphenyllactic acid (9): yel-
lowish solid; 1H NMR (DMSO-d6, 500 MHz) δ 4.08 (1H, dd, J = 4.0,
8.0 Hz, H-2), 5.58 (1H, brs, 2-OH), 2.68 (1H, dd, J = 14.0, 8.0 Hz, H-
3), 2.84 (1H, dd, J = 14.0, 4.0 Hz, H-3′), 7.33 (1H, d, J = 1.5 Hz, H-5),
7.22 (1H, d, J = 1.5 Hz, H-9), 9.75 (1H, s, 7-OH); 13C NMR (DMSO-
d6, 125 MHz) δ 175.3 (C, C-1), 71.0 (CH, C-2), 38.7 (CH2, C-3),
132.4 (C, C-4), 132.9 (CH, C-5), 112.0 (C, C-6), 148.6 (C, C-7),
121.8 (C, C-8), 130.5 (CH, C-9); HRESIMS m/z 292.9211, [M −
H]− (calcd for C9H779Br35ClO4, 292.9216).
Preparation of m,m-Dibromo-D,L-p-hydroxyphenyllactic
Acid (10) (ref 13). To a stirring solution of hydroxyphenyllactic
acid (10 mg) in 2 mL of CH3CN was added 2.0 equiv (19.6 mg) of N-
bromosuccinimide in CH3CN (2 mL) in one portion. The reaction
was left to stir at room temperature for 18 h. For the workup, the
CH3CN solution was diluted with EtOAc (20 mL) and washed three
times with a 5% aqueous solution of Na2S2O3 (25 mL), followed by
three washes with water (25 mL) and then with brine (25 mL). After
evaporation of the solvents under vacuum, the solid was subjected to a
preparative reversed-phase HPLC column (YMC-pack ODS-A, 5 μm,
250 × 20 mm, DAD at 238 nm, flow rate 5.0 mL/min) eluted with 1:1
0.1% aqueous TFA/MeOH to afford m-bromo-D,L-p-Hpla (1.5 mg,
13% yield, retention time 18.9 min) and m,m-dibromo-D,L-p-Hpla (10,
10.9 mg, 58% yield, retention time 25.5 min).
m,m-Dibromo-D,L-p-hydroxyphenyllactic acid (10): yellowish
solid; 1H NMR (DMSO-d6, 500 MHz) δ 4.08 (1H, dd, J = 4.0, 8.0 Hz,
H-2), 5.58 (1H, brs, 2-OH), 2.70 (1H, dd, J = 13.5, 8.0 Hz, H-3), 2.84
(1H, dd, J = 13.5, 4.0 Hz, H-3′), 7.36 (2H, s, H-5, H-9), 9.60 (1H, s, 7-
OH); 13C NMR (DMSO-d6, 125 MHz) δ 175.3 C, C-1), 71.2 (CH, C-
2), 38.5 (CH2, C-3), 132.7 (C, C-4), 133.5 (CH × 2, C-5,5′), 112.0 (C
× 2, C-6,6′), 149.4 (C, C-7); HRESIMS m/z 338.8696, [M − H]−
(calcd for C9H779Br80BrO4, 338.8691).
Preparation of m,m-Dichloro-D,L-p-hydroxyphenyllactic Acid
(11) (ref 13). To a stirring solution of hydroxyphenyllactic acid (10
mg) in 2 mL of CH3CN was added 2.2 equiv (16.1 mg) of N-
chlorosuccinimide in CH3CN (2 mL) in one portion. The reaction
was left to stir at room temperature for 18 h. For the workup, the
CH3CN solution was diluted with EtOAc (20 mL) and washed three
times with a 5% aqueous solution of Na2S2O3, (25 mL) followed by
three washes with water (25 mL) and then with brine (25 mL). After
evaporation of the solvents under vacuum, the solid was subjected to a
preparative reversed-phase HPLC column (YMC-pack ODS-A, 5 μm,
250 × 20 mm, DAD at 238 nm, flow rate 5.0 mL/min) eluted with 1:1
0.1% aqueous TFA/MeOH to afford m-chloro-D,L-p-Hpla (1.4 mg,
12% yield, retention time 13.8 min) and m,m-dichloro-D,L-p-Hpla (11,
5.5 mg, 41% yield, retention time 18.2 min).
Protease Inhibition Assays. The procedures used to determine
the inhibitory activity of the new compounds on trypsin and thrombin
were described in a previous paper.21
ASSOCIATED CONTENT
* Supporting Information
■
S
1D and 2D NMR spectra and HR MS data of compounds 1−5;
tables of full NMR data of 1−5. This material is available free of
AUTHOR INFORMATION
Corresponding Author
■
*Tel: ++972-3-6408550. Fax: ++972-3-6409293. E-mail:
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
The authors thank N. Tal, the Mass Spectrometry Facility of
the School of Chemistry, Tel Aviv University, for the
measurements of the HRESI mass spectra. We thank J.
Bonjoch, Faculty of Pharmacy, University of Barcelona, Spain,
for the kind provision of the synthetic Choi isomers. This
research was supported by the Israel Science Foundation grant
776/06.
REFERENCES
■
(1) Murakami, M.; Okita, Y.; Matsuda, H.; Okino, T.; Yamaguchi, K.
Tetrahedron Lett. 1994, 35, 3129−3132.
(2) Ersmark, K.; Del Valle, J. R.; Hanessian, S. Angew. Chem., Int. Ed.
2008, 47, 1202−1223.
m,m-Dichloro-D,L-p-hydroxyphenyllactic acid (11): yellowish
solid; 1H NMR (DMSO-d6, 500 MHz) δ 4.01 (1H, dd, J = 4.0, 8.0 Hz,
H-2), 5.58 (1H, brs, 2-OH), 2.65 (1H, dd, J = 14.0, 8.0 Hz, H-3), 2.84
(3) Lifshits, M.; Carmeli, S. J. Nat. Prod. 2012, 75, 209−219.
(4) Welker, M.; Marsalek, B.; Sejnhova, L.; von Dohren, H. Peptides
2006, 27, 2090−2103.
2150
dx.doi.org/10.1021/np3005612 | J. Nat. Prod. 2012, 75, 2144−2151